The Securities and Exchange Commission has not necessarily
reviewed the information in this filing and has not determined
if it is accurate and complete.
| |||||||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ALECTOR INC | COM | 014442107 | 2,628,795 | 1,307,858 | SH | SOLE | 1,307,858 | 0 | 0 | ||
| FOGHORN THERAPEUTICS INC | COM | 344174107 | 7,679,954 | 1,573,761 | SH | SOLE | 1,573,761 | 0 | 0 | ||
| ISHARES TR | MSCI INDIA ETF | 46429B598 | 18,254,544 | 369,600 | SH | SOLE | 369,600 | 0 | 0 | ||
| ORIC PHARMACEUTICALS INC | COM | 68622P109 | 10,715,310 | 989,410 | SH | SOLE | 989,410 | 0 | 0 | ||
| PMV PHARMACEUTICALS INC | COM | 69353Y103 | 3,521,042 | 2,627,643 | SH | SOLE | 2,627,643 | 0 | 0 | ||
| SURROZEN INC | COM NEW | 86889P208 | 2,275,711 | 87,696 | SH | SOLE | 87,696 | 0 | 0 | ||
| SURROZEN INC | *W EXP 08/01/203 | 86889P117 | 2,819 | 170,833 | SH | SOLE | 170,833 | 0 | 0 | ||
| TEAMSHARES INC | COM | 87821B109 | 9,041,786 | 1,099,974 | SH | SOLE | 1,099,974 | 0 | 0 | ||
| TENAYA THERAPEUTICS INC | COM | 87990A106 | 750,708 | 1,015,705 | SH | SOLE | 1,015,705 | 0 | 0 | ||
| VANGUARD INDEX FDS | VALUE ETF | 922908744 | 113,323,600 | 520,000 | SH | SOLE | 520,000 | 0 | 0 | ||
| VANGUARD INTL EQUITY INDEX F | ALLWRLD EX US | 922042775 | 271,641,785 | 3,243,484 | SH | SOLE | 3,243,484 | 0 | 0 | ||